Healthcare Realty Trust Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 7, 2026, reports on events occurring on May 4 and May 7, 2026. Healthcare Realty Trust Incorporated (the "Company") and its subsidiary, Healthcare Realty Holdings, L.P. (the "Issuer"), entered into a material definitive agreement to issue exchangeable senior notes and related financial instruments.
Key Financial Metrics and Transaction Details
- Debt Issuance: Issued $700,000,000 aggregate principal amount of 3.00% Exchangeable Senior Notes due 2032. This includes $100,000,000 issued pursuant to the full exercise of an option by initial purchasers.
- Interest Rate: 3.00% per annum, payable semi-annually in arrears beginning January 15, 2027.
- Maturity Date: January 15, 2032.
- Guarantee: The Company has fully and unconditionally guaranteed the Notes on a senior, unsecured basis.
- Exchange Terms: Initial exchange rate is 43.4660 shares of Company common stock per $1,000 principal amount of Notes (approx. $23.01 per share).
- Capped Call Transactions: Entered into transactions with a cost of approximately $28 million. The cap price is approximately $27.41 per share (approx. 40% premium over the $19.58 last reported sale price).
- Potential Dilution: Up to 35,750,750 shares of common stock may be issued upon exchange of the Notes.
Material Changes and Structural Implications
The filing represents a significant increase in the Company's capital structure through the issuance of $700 million in senior unsecured debt. The Notes are senior in right of payment to subordinated indebtedness but effectively subordinated to secured indebtedness and structurally subordinated to liabilities of subsidiaries. The transaction introduces exchangeable features allowing noteholders to convert debt into equity under specific conditions, potentially impacting the Company's share count and earnings per share.
Guidance, Risks, and Contingencies
- Redemption Rights: The Issuer may redeem the Notes on or after January 22, 2030, subject to liquidity conditions and if the Company's stock price exceeds 130% of the exchange price for a specified period.
- Fundamental Change Repurchase: Upon certain corporate events (e.g., business combinations, delisting), noteholders may require the Issuer to repurchase the Notes at 100% of principal plus accrued interest.
- Registration Default Risk: If the Company fails to maintain an effective resale registration statement for shares issuable upon exchange, additional interest may accrue (0.25% for the first 90 days, then 0.50% per annum). A 3% maturity premium applies if a Registration Default Event exists at maturity.
- Events of Default: Includes payment defaults, bankruptcy, failure to exchange notes, and defaults on other indebtedness of $50 million or more.
- Financial Statements: The filing text does not provide updated revenue, profit, cash flow, or liquidity metrics for the Company; it focuses solely on the terms of the new debt instrument.
Key Facts for Investor Verification
- Verify the impact of the $28 million cost of the Capped Call Transactions on the Company's current cash position and net income.
- Confirm the Company's ability to satisfy the liquidity conditions required to redeem the Notes after January 2030.
- Monitor the Company's stock price relative to the $23.01 exchange price and the $27.41 cap price to assess potential dilution or cash settlement obligations.
- Review the Company's compliance with the Registration Rights Agreement to avoid the accrual of additional interest or the 3% maturity premium.
- Assess the Company's total leverage ratio post-issuance, as the filing does not disclose total existing debt levels.